-
It sounds like a good idea, and consultants are throwing it around all the time: Cross-train your staff so you get more out of the same people. But how exactly do you cross-train the staff?
-
This column addresses reader questions about the Emergency Medical Treatment and Labor Act (EMTALA).
-
The new Medicare Prescription Drug, Improvement, and Modernization Act, signed into law by President Bush in early December, contains a victory for pharmacists. However, some drug reimbursement changes are also cause for concern.
-
The Infectious Diseases Society of America (IDSA) has updated its treatment guidelines for community-acquired pneumonia (CAP) in immunocompetent adults, just in time for a season that is expected to have higher-than-normal cases of lung disease.
-
Here are details of the recently approved agreement that is designed to give all Medicare beneficiaries access to prescription drug coverage. Most of these details are provided by the U.S. Department of Health and Human Services.
-
Asthma affects nearly 18 million individuals in the United States. Prevention and reduction of asthma exacerbations are important goals of asthma management.
-
-
In the 2003 recommendations for management of community-acquired pneumonia (CAP) in immunocompetent adults, the Infectious Diseases Society of America (IDSA) in Alexandria, VA, has issued suggestions for initial empiric therapy.
-
Pediatric rule legislation passes Congress; Aggressive atorvastatin therapy halts progression of atherosclerosis; New indications for valganciclovir HCl tablets; Aventis warns of hepatic injury reports with leflunomide (Arava); Seniors most vulnerable to hospital medication errors
-
Pharmacists may expect their patients to switch to less expensive drugs when their copayments increase dramatically. A recent study,
however, suggests that some patients may stop taking their important medications altogether.
